Severe toxicity of skin rash, fever and diarrhea associated with imatinib: case report and review of skin toxicities associated with tyrosine kinase inhibitors

Xuan Huang1, Samir Patel2, Nasir Ahmed2, Karen Seiter2, Delong Liu21Department of Medicine, Richmond University Medical Center, New York, NY, USA; 2Division of Oncology and Hematology, New York Medical College and Westchester Medical Center, New York, NY, USAAbstract: Chronic myeloid leukemia (CML)...

Full description

Bibliographic Details
Published in:	Drug Design, Development and Therapy
Main Authors:	Delong Liu, Karen Seiter, Nasir Ahmed, Samir Patel, Xuan Huang
Format:	Article
Language:	English
Published:	Dove Medical Press 2008-10-01
Online Access:	http://www.dovepress.com/severe-toxicity-of-skin-rash-fever-and-diarrhea-associated-with-imatin-a2506

Similar Items

Team Management of Skin Rash Associated with Use of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors
by: Katsuhiro Masago, et al.
Published: (2018-01-01)

Acneiform rash — skin toxic reaction to the use of EGFR inhibitors
by: E. A. Shatokhina, et al.
Published: (2019-01-01)

Possible Role of Interleukin-31/33 Axis in Imatinib Mesylate-Associated Skin Toxicity
by: Caterina Musolino, et al.
Published: (2015-05-01)

Lamotrigine-Associated Skin Rash
by: J Gordon Millichap
Published: (1999-08-01)

Severe Skin Rash Associated with Atazanavir
by: Andrew Walkty, et al.
Published: (2009-01-01)

A child with fever, vomiting, diarrhea, and rash
by: Nicholas M. Perera, et al.
Published: (2022-08-01)

Skin Rash and Fever of Unknown Origin - A Diagnostic Challenge
by: Albina Moreira, et al.
Published: (2019-01-01)

Role of systemic antibiotics in preventing epidermal growth factor receptor: Tyrosine kinase inhibitors-induced skin toxicities
by: Philomena Charlotte Dsouza, et al.
Published: (2017-01-01)

Mechanism and treatment of diarrhea associated with tyrosine kinase inhibitors
by: Jiangnan Liu, et al.
Published: (2024-03-01)

Diffuse skin rash in tropical areas: Dengue fever or COVID-19?,
by: Isabelle Pastor Bandeira, et al.
Published: (2021-03-01)

Severe lichenified skin rash associated with apalutamide administration
by: Chisato Watanabe, et al.
Published: (2025-07-01)

Skin Toxicities Induced by Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and their Influence on Treatment Adjustments in Lung Cancer Patients
by: Ji Su Lee, et al.
Published: (2024-08-01)

Ibrutinib-Induced Skin Rash
by: Sudhir Kirar, et al.
Published: (2021-02-01)

Maculopapular rash in brown skin
by: Ashley Allen, et al.
Published: (2023-12-01)

Lamotrigine-Related Skin Rash
by: J. Jokubaitė, et al.
Published: (2023-12-01)

Carbamazepine-Induced Skin Rash
by: J Gordon Millichap
Published: (1993-07-01)

Lamotrigine-Induced Skin Rash
by: J Gordon Millichap
Published: (1996-04-01)

Lamotrigine-Related Skin Rash
by: J. Jokubaitė, et al.
Published: (2023-12-01)

An adult male with abdominal pain and skin rash
by: Jay Patel, et al.
Published: (2014-12-01)

Usefulness of diverse serological tests in the laboratory diagnosis of fever with skin-rash cases in children
by: Vaidya SR, et al.
Published: (2022-06-01)

Woman with dyspnea after skin rash
by: Naoki Yamagata, et al.
Published: (2023-02-01)

P657: PATHOGENESIS OF TYROSINE KINASE INHIBITOR–ASSOCIATED VASCULAR TOXICITY IN CHRONIC MYELOID LEUKEMIA
by: Ayala Gover Proaktor, et al.
Published: (2023-08-01)

Ibrutinib-associated skin toxicity: a case of maculopapular rash in a 79-year old Caucasian male patient with relapsed Waldenstrom’s macroglobulinemia and review of the literature
by: Anders Bisgaard Jensen, et al.
Published: (2017-04-01)

Tyrosine Kinase Inhibitors for Gastrointestinal Stromal Tumor After Imatinib Resistance
by: Xian-Hao Xiao, et al.
Published: (2025-07-01)

Skin rash could predict the response to EGFR tyrosine kinase inhibitor and the prognosis for patients with non-small cell lung cancer: a systematic review and meta-analysis.
by: Hong-bing Liu, et al.
Published: (2013-01-01)

Young man with hodgkin disease with skin rash
by: Suresh VS Attili, et al.
Published: (2019-01-01)

Risk of Serious Skin Rash with Antiepileptic Drugs
by: J Gordon Millichap
Published: (1997-09-01)

Escitalopram-induced skin rash: Dermatitis medicamentosa
by: Sangha M Godi, et al.
Published: (2022-01-01)

Risperidone-induced skin rash in an elderly female
by: Mansi Shah, et al.
Published: (2019-01-01)

The relationship between skin rash and outcome in dengue
by: Ajay Kumar Mishra, et al.
Published: (2018-01-01)

Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Should Be Kept in Mind in Children with Febrile Neutropenia, Oral Cavity Lesions, and Skin Rash
by: Eda Ataseven, et al.
Published: (2016-05-01)

Cardiovascular Toxicity of Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia
by: IL Davydkin, et al.
Published: (2018-10-01)

Differential toxicities of tyrosine kinase inhibitors in the management of metastatic lung cancer
by: Karthik S Udupa, et al.
Published: (2017-01-01)

A case of neonatal lupus presenting with fever and skin rash in a 47-day-old girl
by: Yoonkyeom Shin, et al.
Published: (2021-06-01)

Granulomatous Hepatitis in Association with Fever and a Palmar Rash
by: Desmond J. Leddin, et al.
Published: (1987-01-01)

Granulomatous Hepatitis in Association with Fever and a Palmar Rash
by: Desmond J Leddin, et al.
Published: (1987-01-01)

The Mechanisms of Resistance to Tyrosine Kinase Inhibitor Imatinib Therapy of Chronic Myeloid Leukemia
by: S. I. Kutsev, et al.
Published: (2010-06-01)

The Role of STAT5 in Tyrosine Kinase Inhibitor (IMATINIB) Resistance in CML Patients
by: Anastasia Putri, et al.
Published: (2020-02-01)

The Role of STAT5 in Tyrosine Kinase Inhibitor (IMATINIB) Resistance in CML Patients
by: Anastasia Putri, et al.
Published: (2020-02-01)

Association between efficacy and skin rash following treatment with the lapatinib in metastatic breast cancer
by: Suleyman Temiz, et al.
Published: (2016-04-01)